A Japanese multicenter phase II study of adjuvant chemotherapy with mFOLFOX6/CAPOX for stage III colon cancer treatment after D2/D3 lymphadenectomy

Kazuhiko Yoshimatsu,Keiichiro Ishibashi,Keiji Koda,Hajime Yokomizo,Noritaka Oda,Mitsuru Oshiro,Hiroyuki Kato,Masatoshi Oya,Hideo Nakajima,Shinji Ooki,Hiroshi Maekawa,Toshio Matsunami,Masahiro Tsubaki,Takeshi Yamada,Michiya Kobayashi,Kohji Tanakaya,Masaru Yokoyama,Hideyuki Ishida

A Japanese multicenter phase II study of adjuvant chemotherapy with mFOLFOX6/CAPOX for stage III colon cancer treatment after D2/D3 lymphadenectomy

2019

Kazuhiko Yoshimatsu
Keiichiro Ishibashi
Keiji Koda
Hajime Yokomizo
Noritaka Oda
Mitsuru Oshiro
Hiroyuki Kato
Masatoshi Oya
Hideo Nakajima
Shinji Ooki
Hiroshi Maekawa
Toshio Matsunami
Masahiro Tsubaki
Takeshi Yamada
Michiya Kobayashi
Kohji Tanakaya
Masaru Yokoyama
Hideyuki Ishida

Purpose A phase II trial was conducted to investigate the benefit of oxaliplatin-based adjuvant chemotherapy in Japanese stage III colon cancer patients.

Keywords:

Oncology
Surgery
Phases of clinical research
Adjuvant
Internal medicine
Stage III Colon Cancer
Medicine
Chemotherapy
Lymphadenectomy
Oxaliplatin
Risk factor
Stage IIIC
Clinical endpoint
Surgical oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations